Skip to main content
. 2017 Apr 27;2017(4):CD012631. doi: 10.1002/14651858.CD012631
OTHER TRIAL INFORMATION
Aim of trial
Country/Countries
Trial design
(parallel/cross‐over, single centre/multicentre)
Trial duration
(intervention and follow‐up)
Weeks, months, years, not stated
Definition of hypoxaemia, normoxaemia and hyperoxaemia by trialist Hypoxaemia:
Normoxaemia:
Hyperoxaemia:
The trial included only participants admitted to ICU?
Which targets did the participants actually achieve?
Withdrawals Were these described?
Study funding source
(Incl. role of funders)
Possible conflicts of interest
(for study authors)
Other
Notes